Centessa Pharmaceuticals plc financial data

Symbol
CNTA on Nasdaq
Industry
Pharmaceutical Preparations
Location
3 Rd Floor, 1 Ashley Road, Altrincham, Cheshire, United Kingdom
State of incorporation
United Kingdom
Fiscal year end
December 31
Former names
Centessa Pharmaceuticals Ltd (to 5/24/2021)
Latest financial report
Q1 2024 - May 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 945 % -27.3%
Debt-to-equity 47.7 % +59.3%
Return On Equity -56.1 % +6.13%
Return On Assets -38 % +17.4%
Operating Margin -2.5K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 100M shares +5.63%
Common Stock, Shares, Outstanding 100M shares +5.66%
Entity Public Float 311M USD +28.7%
Common Stock, Value, Issued 277K USD +4.14%
Weighted Average Number of Shares Outstanding, Basic 99.9M shares +5.21%
Weighted Average Number of Shares Outstanding, Diluted 99.9M shares +5.21%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 6.85M USD
General and Administrative Expense 51.1M USD -10.1%
Operating Income (Loss) -158M USD +23.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -164M USD +23%
Income Tax Expense (Benefit) -25.3M USD -16735%
Net Income (Loss) Attributable to Parent -138M USD +34.8%
Earnings Per Share, Basic -1.42 USD/shares +36.6%
Earnings Per Share, Diluted -1.42 USD/shares +36.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 118M USD -54.5%
Other Assets, Current 1.8M USD -42.5%
Assets, Current 284M USD -26%
Deferred Income Tax Assets, Net 29.2M USD
Property, Plant and Equipment, Net 952K USD -21.9%
Operating Lease, Right-of-Use Asset 11.7M USD -4.7%
Other Assets, Noncurrent 1.88M USD -68.8%
Assets 328M USD -18.7%
Accounts Payable, Current 7.5M USD -47.8%
Employee-related Liabilities, Current 2.86M USD -3.51%
Accrued Liabilities, Current 19.9M USD +30.1%
Liabilities, Current 27.4M USD -7.58%
Operating Lease, Liability, Noncurrent 8.74M USD -6.11%
Other Liabilities, Noncurrent 29K USD
Liabilities 113M USD +2.18%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.62M USD
Retained Earnings (Accumulated Deficit) -791M USD -21.2%
Stockholders' Equity Attributable to Parent 215M USD -26.6%
Liabilities and Equity 328M USD -18.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -37.3M USD +22.1%
Net Cash Provided by (Used in) Financing Activities 10.5M USD
Net Cash Provided by (Used in) Investing Activities 16.8M USD
Common Stock, Shares Authorized 153M shares 0%
Common Stock, Shares, Issued 100M shares +5.66%
Common Stock, Par or Stated Value Per Share 0 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.81M USD +92.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 118M USD -54.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.53M USD +7.89%
Deferred Tax Assets, Valuation Allowance 73.2M USD -22%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.24 pure +26.3%
Deferred Tax Assets, Gross 106M USD +8.47%
Operating Lease, Liability 9.27M USD -4.52%
Depreciation 86K USD +132%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -136M USD +36.1%
Lessee, Operating Lease, Liability, to be Paid 15.2M USD -9.39%
Property, Plant and Equipment, Gross 1.5M USD +5.7%
Operating Lease, Liability, Current 528K USD +32.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.67M USD +2.02%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.63M USD +2%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Deferred Income Tax Expense (Benefit) 434K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.95M USD -16.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.7M USD +1.98%
Deferred Tax Assets, Operating Loss Carryforwards 77.4M USD +5.94%
Deferred Federal Income Tax Expense (Benefit) -26.3M USD -966%
Unrecognized Tax Benefits 2.61M USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.73M USD +2%
Operating Lease, Payments 400K USD
Additional Paid in Capital 1B USD +6.14%
Current State and Local Tax Expense (Benefit) 233K USD -56.4%
Current Federal Tax Expense (Benefit) 1.24M USD -21.5%
Depreciation, Depletion and Amortization 240K USD +170%
Deferred Tax Assets, Net of Valuation Allowance 32.4M USD +822%
Share-based Payment Arrangement, Expense 30.4M USD +14.8%
Deferred State and Local Income Tax Expense (Benefit) -256K USD +34.7%
Interest Expense 10.1M USD +24.2%